Article
Non-ANCA Leucocytoclasic Vasculitis Induced by Sofosbuvir/Ledipasvir Treatment: A Case Report.
Current drug safety - 1 Jan 2024
Zaimi Yosra, Ayari Myriam, Ghithia Nadine, Ayadi Shema
Abstract excerpt
BACKGROUND: The development of direct-acting antivirals directed against the Hepatitis C Virus has dramatically modified the therapeutic approach to chronic hepatic viral disease. Larger use of such drugs has also led to increasing reports about their adverse effects. This report aimed to describe a case of leucocytoclasic vasculitis following treatment based on the sofosbuvir/ledipasvir regimen with complete...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
